These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8254619)

  • 1. Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.
    Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS; Zavoico GB
    J Med Chem; 1993 Nov; 36(24):3871-83. PubMed ID: 8254619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4,5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.
    Meanwell NA; Romine JL; Rosenfeld MJ; Martin SW; Trehan AK; Wright JJ; Malley MF; Gougoutas JZ; Brassard CL; Buchanan JO
    J Med Chem; 1993 Nov; 36(24):3884-903. PubMed ID: 7504734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moiety.
    Meanwell NA; Rosenfeld MJ; Trehan AK; Romine JL; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M
    J Med Chem; 1992 Sep; 35(19):3498-512. PubMed ID: 1404231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4,5-Diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid modified beta-to the oxazole ring.
    Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Hartl KS
    Drug Des Discov; 1994 Jan; 11(1):73-89. PubMed ID: 7520762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.
    Meanwell NA; Rosenfeld MJ; Trehan AK; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Gamberdella M; Zavoico GB
    J Med Chem; 1992 Sep; 35(19):3483-97. PubMed ID: 1404230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic.
    Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Seiler SM
    J Med Chem; 1992 Jan; 35(2):389-97. PubMed ID: 1370696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-[3-[2-(4,5-Diphenyl-2-oxazolyl) ethyl] phenoxy] acetic acid (BMY 42393): a new, structurally-novel prostacyclin partial agonist: 1). Inhibition of platelet aggregation and mechanism of action.
    Seiler SM; Brassard CL; Federici ME; Buchanan JO; Zavoico GB; Fleming JS; Meanwell NA
    Thromb Res; 1994 Apr; 74(2):115-23. PubMed ID: 8029812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding.
    Seiler SM; Brassard CL; Federici ME; Romine J; Meanwell NA
    Prostaglandins; 1997 Jan; 53(1):21-35. PubMed ID: 9068064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
    Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of prostacyclin mimetics distinguishes neuronal from neutrophil IP receptors.
    Wise H; Qian YM; Jones RL
    Eur J Pharmacol; 1995 May; 278(3):265-9. PubMed ID: 7589166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperidine derivatives as nonprostanoid IP receptor agonists 2.
    Hayashi R; Ito H; Ishigaki T; Morita Y; Miyamoto M; Isogaya M
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2886-2889. PubMed ID: 27133594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel pyridazinone derivative as a nonprostanoid PGI2 agonist.
    Tsubaki K; Taniguchi K; Tabuchi S; Okitsu O; Hattori K; Seki J; Sakane K; Tanaka H
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2787-90. PubMed ID: 11133092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SQ-27986 inhibition of platelet aggregation is mediated through activation of platelet prostaglandin D2 receptors.
    Seiler S; Brassard CL; Federici ME
    Prostaglandins; 1990 Aug; 40(2):119-30. PubMed ID: 2171039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: orally active prostacyclin mimetics. Part 6.
    Tanaka A; Hattori K; Taniguchi K; Okitsu O; Tabuchi S; Nishio M; Nagakura Y; Maeda N; Murai H; Seki J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4861-4. PubMed ID: 16837197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.